Which hedge funds own INDV? INDIVIOR PHARMACEUTICALS INC, Q2 2026 13F holders
46 tracked hedge funds disclosed a position in INDV (INDIVIOR PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $1.3bn in total. The largest holder by portfolio weight is Mangrove Partners IM, LLC at 7.2% of its book. 12 opened a new position this quarter: Stonepine Capital Management, LLC, Parkman Healthcare Partners LLC, Oxford Asset Management LLP, Aquatic Capital Management LLC. 12 exited: Krensavage Asset Management, LLC, Riposte Capital LLC, Tejara Capital Ltd.
- 46
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 12
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 12
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $46.9m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $65.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.3bn
- Combined value Sum of the holders' reported positions in the security.
- 3.7%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Krensavage Asset Management, LLC | 4.0% | $10.3m |
| Riposte Capital LLC | 2.8% | $6.1m |
| Tejara Capital Ltd | 1.1% | $3.4m |
| Mirabella Financial Services LLP | 0.3% | $2.9m |
| Scientech Research LLC | 0.3% | $311k |
| Rubric Capital Management LP | 0.2% | $20.2m |
| Weiss Asset Management LP | 0.1% | $7.9m |
| Hudson Bay Capital Management LP | 0.07% | $11.1m |
| FORA Capital, LLC | 0.05% | $709k |
| Occudo Quantitative Strategies LP | 0.04% | $746k |
| Engineers Gate Manager LP | 0.02% | $1.2m |
| Walleye Capital LLC | 0.0% | $538k |
Ownership over time
Who discovered INDV first? Beta
| Mangrove Partners IM, LLC high conviction | Q1 2026 | +2.3 pts |
| Newtyn Management, LLC high conviction | Q1 2026 | +2.3 pts |
| Two Seas Capital LP high conviction | Q1 2026 | +1.6 pts |
| Oaktree Capital Management LP | Q1 2026 | +1.2 pts |
| Melqart Asset Management (UK) Ltd | Q1 2026 | +0.7 pts |
| PFM Health Sciences, LP | Q1 2026 | +0.6 pts |
| Soleus Capital Management, L.P. | Q1 2026 | +0.5 pts |
| Madison Avenue Partners, LP high conviction | Q4 2025 | +0.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.